Burning Rock Biotech

(NASDAQ) BNR

Current Price$6.91

Market Cap$71.43M

Since IPO (2020)-97%

5 Year-97%

1 Year+140%

1 Month-52%

Burning Rock Biotech Financials at a Glance

Market Cap

$71.43M

Revenue (TTM)

CN¥514.43M

Net Income (TTM)

-CN¥59.32M

EPS (TTM)

-$0.79

P/E Ratio

-10.32

Dividend

$0.00

Beta (Volatility)

1.17 (Average)

Dividend

$0.00

Beta (Volatility)

1.17 (Average)

Price

$6.91

Volume

49,547

Open

$8.13

Price

$6.91

Volume

49,547

Open

$8.13

Previous Close

$7.04

Daily Range

$6.79 - $8.13

52-Week Range

$3.06 - $41.72

Estimated Earnings Date

Sep 2, 2026

Dividend

$0.00

Beta (Volatility)

1.17 (Average)

Price

$6.91

Volume

49,547

Open

$8.13

Previous Close

$7.04

Daily Range

$6.79 - $8.13

52-Week Range

$3.06 - $41.72

Estimated Earnings Date

Sep 2, 2026

BNR News

No articles available.

BNR: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Burning Rock Biotech

Industry

Biotechnology

Sector

Health Care

Employees

667

CEO

Yu Sheng Han, MBA

Website

www.brbiotech.com

Headquarters

Guangzhou, 510005, CN

BNR Financials

Key Financial Metrics (TTM)

Gross Margin

75%

Operating Margin

-11%

Net Income Margin

-12%

Return on Equity

-11%

Return on Capital

-10%

Return on Assets

-8%

Earnings Yield

-9.69%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$71.43M

Shares Outstanding

8.79M

Volume

49.55K

Avg. Volume

26.82K

Financials (TTM)

Gross Profit

CN¥402.91M

Operating Income

-CN¥54.85M

EBITDA

-CN¥32.00M

Operating Cash Flow

-CN¥28.44M

Capital Expenditure

-CN¥5.25M

Free Cash Flow

-CN¥33.69M

Cash & ST Invst.

CN¥481.39M

Total Debt

CN¥43.15M

Burning Rock Biotech Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

CN¥107.94M

-18.9%

Gross Profit

CN¥78.01M

-19.9%

Gross Margin

72.27%

N/A

Market Cap

$71.43M

N/A

Market Cap/Employee

$105.98K

N/A

Employees

674

N/A

Net Income

-CN¥17.47M

-29.4%

EBITDA

-CN¥17.23M

-29.7%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

CN¥446.00M

-9.9%

Total Debt

CN¥50.86M

+20.1%

Accounts Receivable

CN¥177.21M

+0.3%

Inventory

CN¥54.29M

-17.0%

Long Term Debt

CN¥29.55M

+49.1%

Short Term Debt

CN¥21.31M

-5.4%

Return on Assets

-7.53%

N/A

Return on Invested Capital

-10.49%

N/A

Free Cash Flow

CN¥17.79M

+30.4%

Operating Cash Flow

CN¥23.04M

+20.9%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

EKSOEkso Bionics Holdings, Inc.

EKSOEkso Bionics Holdings, Inc.$20.64+7.89%

AYTUAytu BioPharma, Inc.

AYTUAytu BioPharma, Inc.$2.11+1.20%

PMNProMIS Neurosciences, Inc.

PMNProMIS Neurosciences, Inc.$10.38+2.17%

ADVBAdvanced Biomed Inc. Common Stock

ADVBAdvanced Biomed Inc. Common Stock$4.75+5.32%

CODXCo-Diagnostics, Inc.

CODXCo-Diagnostics, Inc.$3.33-13.28%

AEMDAethlon Medical, Inc.

AEMDAethlon Medical, Inc.$1.91-1.04%

PRPHProPhase Labs, Inc.

PRPHProPhase Labs, Inc.$0.08-3.16%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

ICCMIceCure Medical

ICCMIceCure Medical$6.40+2.00%

AALAmerican Airlines Group

AALAmerican Airlines Group$15.42-0.02%

SOFISoFi Technologies

SOFISoFi Technologies$17.42-0.02%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.54-0.03%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$39.52+0.03%

HOODRobinhood Markets

HOODRobinhood Markets$105.20+0.09%

KEELKeel Infrastructure

KEELKeel Infrastructure$5.97+0.00%

Questions About BNR

What is the current price of Burning Rock Biotech?

Burning Rock Biotech is trading at $7.04 per share.

What is the 52-week range for Burning Rock Biotech?

Over the past 52 weeks, Burning Rock Biotech has traded between $3.06 and $41.72.

How much debt does Burning Rock Biotech have?

As of the most recent reporting period, Burning Rock Biotech reported total debt of CN¥7.36M.

How much cash does Burning Rock Biotech have on hand?

Burning Rock Biotech reported CN¥64.96M in cash and cash equivalents in its most recent financial results.

What is Burning Rock Biotech’s dividend yield?

Burning Rock Biotech does not currently have a dividend yield.

Burning Rock Biotech

Burning Rock Biotech Financials at a Glance

BNR News

BNR: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Burning Rock Biotech

BNR Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Burning Rock Biotech Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About BNR

What is the current price of Burning Rock Biotech?

What is the 52-week range for Burning Rock Biotech?

How much debt does Burning Rock Biotech have?

How much cash does Burning Rock Biotech have on hand?

What is Burning Rock Biotech’s dividend yield?

Premium Investing Services